A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
Shigehisa KubotaTetsuya YoshidaSusumu KageyamaTakahiro IsonoTakeshi YuasaJunji YoneseRyoji KushimaAkihiro KawauchiTokuhiro ChanoPublished in: World journal of surgical oncology (2020)
Our findings indicate that a prognostic model based on four novel biomarkers provides valuable data for prediction of clinical prognosis and useful information for considering the follow-up conditions and therapeutic strategies for patients with primary and metastatic RCC.